Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells

Chien Sung Tsai, Shih Hurng Loh, Ju Chi Liu, Jia Wei Lin, Yen Ling Chen, Cheng Hsien Chen, Tzu-Hurng Cheng

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Urotensin II (U-II) is implicated in vascular smooth muscle cell proliferation, which results in vascular remodeling. We recently demonstrated that both reactive oxygen species (ROS) generation and epidermal growth factor receptor (EGFR) transactivation play critical roles in U-II signal transduction. However, the detailed intracellular mechanism of U-II in vascular smooth muscle cells remains unclear. In this study, we used rat aortic smooth muscle cells treated with U-II to investigate the connection between ROS generation and EGFR transactivation. U-II treatment was found to stimulate endothelin-1 (ET-1) expression and cell proliferation through the phosphorylation of EGFR and ROS generation. NAD(P)H oxidase inhibitor apocynin and ROS scavenger N-acetylcysteine (NAC) inhibited the EGFR transactivation induced by U-II. In contrast, AG-1478 (an EGFR inhibitor) failed to inhibit intracellular ROS generation induced by U-II. Src homology 2-containing tyrosine phosphatase (SHP-2) was shown to be associated with EGFR during U-II treatment by EGFR coimmunoprecipitation. ROS have been reported to oxidize the catalytic cysteine of SHP-2 and inhibit its activity. We examined the effect of U-II on SHP-2 in smooth muscle cells using a modified malachite green phosphatase assay. SHP-2 was oxidized during U-II treatment; and this oxidization could be repressed by NAC treatment. In SHP-2 knockdown cells, U-II-induced EGFR phosphorylation, ET-1 secretion, and cell proliferation were enhanced, and were not influenced by NAC. Our data suggest that U-II-mediated ROS generation can inhibit SHP-2 activity to facilitate the EGFR transactivation and mitogenic signal transduction in rat aortic smooth muscle cells.

Original languageEnglish
Pages (from-to)86-94
Number of pages9
JournalAtherosclerosis
Volume206
Issue number1
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Endothelin-1
Epidermal Growth Factor Receptor
Transcriptional Activation
Smooth Muscle Myocytes
Cell Proliferation
Reactive Oxygen Species
Acetylcysteine
Vascular Smooth Muscle
Phosphoric Monoester Hydrolases
urotensin II
Signal Transduction
Phosphorylation
NADPH Oxidase
Cysteine

Keywords

  • Endothelin-1
  • Epidermal growth factor receptor transactivation
  • Reactive oxygen species
  • Smooth muscle cell proliferation
  • Src homology 2-containing phosphotyrosine phosphatase
  • Urotensin II

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. / Tsai, Chien Sung; Loh, Shih Hurng; Liu, Ju Chi; Lin, Jia Wei; Chen, Yen Ling; Chen, Cheng Hsien; Cheng, Tzu-Hurng.

In: Atherosclerosis, Vol. 206, No. 1, 09.2009, p. 86-94.

Research output: Contribution to journalArticle

@article{1a21a095cb7b48aaa69defb43a4eac95,
title = "Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells",
abstract = "Urotensin II (U-II) is implicated in vascular smooth muscle cell proliferation, which results in vascular remodeling. We recently demonstrated that both reactive oxygen species (ROS) generation and epidermal growth factor receptor (EGFR) transactivation play critical roles in U-II signal transduction. However, the detailed intracellular mechanism of U-II in vascular smooth muscle cells remains unclear. In this study, we used rat aortic smooth muscle cells treated with U-II to investigate the connection between ROS generation and EGFR transactivation. U-II treatment was found to stimulate endothelin-1 (ET-1) expression and cell proliferation through the phosphorylation of EGFR and ROS generation. NAD(P)H oxidase inhibitor apocynin and ROS scavenger N-acetylcysteine (NAC) inhibited the EGFR transactivation induced by U-II. In contrast, AG-1478 (an EGFR inhibitor) failed to inhibit intracellular ROS generation induced by U-II. Src homology 2-containing tyrosine phosphatase (SHP-2) was shown to be associated with EGFR during U-II treatment by EGFR coimmunoprecipitation. ROS have been reported to oxidize the catalytic cysteine of SHP-2 and inhibit its activity. We examined the effect of U-II on SHP-2 in smooth muscle cells using a modified malachite green phosphatase assay. SHP-2 was oxidized during U-II treatment; and this oxidization could be repressed by NAC treatment. In SHP-2 knockdown cells, U-II-induced EGFR phosphorylation, ET-1 secretion, and cell proliferation were enhanced, and were not influenced by NAC. Our data suggest that U-II-mediated ROS generation can inhibit SHP-2 activity to facilitate the EGFR transactivation and mitogenic signal transduction in rat aortic smooth muscle cells.",
keywords = "Endothelin-1, Epidermal growth factor receptor transactivation, Reactive oxygen species, Smooth muscle cell proliferation, Src homology 2-containing phosphotyrosine phosphatase, Urotensin II",
author = "Tsai, {Chien Sung} and Loh, {Shih Hurng} and Liu, {Ju Chi} and Lin, {Jia Wei} and Chen, {Yen Ling} and Chen, {Cheng Hsien} and Tzu-Hurng Cheng",
year = "2009",
month = "9",
doi = "10.1016/j.atherosclerosis.2009.02.013",
language = "English",
volume = "206",
pages = "86--94",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells

AU - Tsai, Chien Sung

AU - Loh, Shih Hurng

AU - Liu, Ju Chi

AU - Lin, Jia Wei

AU - Chen, Yen Ling

AU - Chen, Cheng Hsien

AU - Cheng, Tzu-Hurng

PY - 2009/9

Y1 - 2009/9

N2 - Urotensin II (U-II) is implicated in vascular smooth muscle cell proliferation, which results in vascular remodeling. We recently demonstrated that both reactive oxygen species (ROS) generation and epidermal growth factor receptor (EGFR) transactivation play critical roles in U-II signal transduction. However, the detailed intracellular mechanism of U-II in vascular smooth muscle cells remains unclear. In this study, we used rat aortic smooth muscle cells treated with U-II to investigate the connection between ROS generation and EGFR transactivation. U-II treatment was found to stimulate endothelin-1 (ET-1) expression and cell proliferation through the phosphorylation of EGFR and ROS generation. NAD(P)H oxidase inhibitor apocynin and ROS scavenger N-acetylcysteine (NAC) inhibited the EGFR transactivation induced by U-II. In contrast, AG-1478 (an EGFR inhibitor) failed to inhibit intracellular ROS generation induced by U-II. Src homology 2-containing tyrosine phosphatase (SHP-2) was shown to be associated with EGFR during U-II treatment by EGFR coimmunoprecipitation. ROS have been reported to oxidize the catalytic cysteine of SHP-2 and inhibit its activity. We examined the effect of U-II on SHP-2 in smooth muscle cells using a modified malachite green phosphatase assay. SHP-2 was oxidized during U-II treatment; and this oxidization could be repressed by NAC treatment. In SHP-2 knockdown cells, U-II-induced EGFR phosphorylation, ET-1 secretion, and cell proliferation were enhanced, and were not influenced by NAC. Our data suggest that U-II-mediated ROS generation can inhibit SHP-2 activity to facilitate the EGFR transactivation and mitogenic signal transduction in rat aortic smooth muscle cells.

AB - Urotensin II (U-II) is implicated in vascular smooth muscle cell proliferation, which results in vascular remodeling. We recently demonstrated that both reactive oxygen species (ROS) generation and epidermal growth factor receptor (EGFR) transactivation play critical roles in U-II signal transduction. However, the detailed intracellular mechanism of U-II in vascular smooth muscle cells remains unclear. In this study, we used rat aortic smooth muscle cells treated with U-II to investigate the connection between ROS generation and EGFR transactivation. U-II treatment was found to stimulate endothelin-1 (ET-1) expression and cell proliferation through the phosphorylation of EGFR and ROS generation. NAD(P)H oxidase inhibitor apocynin and ROS scavenger N-acetylcysteine (NAC) inhibited the EGFR transactivation induced by U-II. In contrast, AG-1478 (an EGFR inhibitor) failed to inhibit intracellular ROS generation induced by U-II. Src homology 2-containing tyrosine phosphatase (SHP-2) was shown to be associated with EGFR during U-II treatment by EGFR coimmunoprecipitation. ROS have been reported to oxidize the catalytic cysteine of SHP-2 and inhibit its activity. We examined the effect of U-II on SHP-2 in smooth muscle cells using a modified malachite green phosphatase assay. SHP-2 was oxidized during U-II treatment; and this oxidization could be repressed by NAC treatment. In SHP-2 knockdown cells, U-II-induced EGFR phosphorylation, ET-1 secretion, and cell proliferation were enhanced, and were not influenced by NAC. Our data suggest that U-II-mediated ROS generation can inhibit SHP-2 activity to facilitate the EGFR transactivation and mitogenic signal transduction in rat aortic smooth muscle cells.

KW - Endothelin-1

KW - Epidermal growth factor receptor transactivation

KW - Reactive oxygen species

KW - Smooth muscle cell proliferation

KW - Src homology 2-containing phosphotyrosine phosphatase

KW - Urotensin II

UR - http://www.scopus.com/inward/record.url?scp=68949206488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949206488&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2009.02.013

DO - 10.1016/j.atherosclerosis.2009.02.013

M3 - Article

C2 - 19269634

AN - SCOPUS:68949206488

VL - 206

SP - 86

EP - 94

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -